Presentation Accelerated Platelet Inhibition by Switching from Atorvastatin to a Non-CYP3A4-Metabolized Statin Presenter: Y. Park April 24, 2012 REGISTER for free or LOG IN to view this content CAD Pharma Lipids Factoid Up Next Presentation TCTAP 2012 When is TAVR Not Cost-Effective? Presenter: David J. Cohen April 25, 2012 More slides + Presentation TCTAP 2012 What’s the Benchmark: Is there a Gold Standard for SFA Revascularization? Presenter: Lawrence A. Garcia April 25, 2012 Presentation TCTAP 2012 Valve-in-valve TAVI Implantation Presenter: Eberhard Grube April 25, 2012 We Recommend
Presentation TCTAP 2012 What’s the Benchmark: Is there a Gold Standard for SFA Revascularization? Presenter: Lawrence A. Garcia April 25, 2012